M&A

Boston Scientific bets on cardiac wearables with $925M Preventice buy
Boston Scientific bets on cardiac wearables with $925M Preventice buy
Medtech Dive
Boston Scientific
M&A
Preventice
cardiac monitoring
cardiac wearables
wearables
Flag link:
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
BioPharma Dive
Bayer
AskBio
M&A
gene therapy
Flag link:
Haemonetics inks $510M Cardiva takeover to expand hospital business
Haemonetics inks $510M Cardiva takeover to expand hospital business
Medtech Dive
devices
M&A
Haemonetics
Cardiva Medical
vascular closure systems
Flag link:
Hillrom makes cardiac monitoring play with $375M Bardy Dx buy
Hillrom makes cardiac monitoring play with $375M Bardy Dx buy
Medtech Dive
Hill-Rom
Bardy Diagnostics
M&A
diagnostics
devices
cardiology
cardiac monitoring
Flag link:
Thermo Fisher to acquire company with COVID-19 test
Thermo Fisher to acquire company with COVID-19 test
Marketwatch
ThermoFisher Scientific
M&A
diagnostics
COVID-19
Mesa Biotech
Flag link:
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
Acquisitions of Biotech Startups Increased in 2020, With No Signs of Slowing Down
Acquisitions of Biotech Startups Increased in 2020, With No Signs of Slowing Down
BioSpace
M&A
biotech
startups
Flag link:
Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals
Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals
Pharmaceutical Business Review
Amneal
Kashiv BioSciences
M&A
Flag link:
Medtech M&A to take off after pandemic slowed deals in 2020: EY
Medtech M&A to take off after pandemic slowed deals in 2020: EY
Medtech Dive
devices
M&A
Medtech
pandemic
COVID-19
Flag link:
Sanofi inks $1.1B Kymab buyout to bag midphase eczema drug
Sanofi inks $1.1B Kymab buyout to bag midphase eczema drug
Fierce Biotech
Sanofi
Kymab
M&A
atopic dermatitis
eczema
monoclonal antibodies
Flag link:
Biopharma Companies Entering 2021 With New Collabs, Partnerships
Biopharma Companies Entering 2021 With New Collabs, Partnerships
BioSpace
M&A
Argenx
Zai Lab
Dewpoint Therapeutics
Pfizer
CureVac
Bayer
Sanofi
Nurix Therapeutics
Flag link:
COVID-19's Effect on Biopharma M&As in 2020
COVID-19's Effect on Biopharma M&As in 2020
BioSpace
M&A
COVID-19
pandemic
Flag link:
3 Things to Expect from OPKO Health in 2021
3 Things to Expect from OPKO Health in 2021
Motley Fool
OPKO Health
diagnostics
COVID-19
pandemic
M&A
Flag link:
Stryker buys sensor maker in bet on wearables in orthopaedics
Stryker buys sensor maker in bet on wearables in orthopaedics
Medtech Dive
Stryker
M&A
OrthoSensor
joint replacements
Orthopedics
wearables
Flag link:
AmerisourceBergen to buy Walgreens' Alliance Healthcare for $6.5B
AmerisourceBergen to buy Walgreens' Alliance Healthcare for $6.5B
Beckers Hospital Review
M&A
AmerisourceBergen
Walgreens Boots Alliance
Alliance Healthcare
Flag link:
Astrazeneca shows megamergers were still possible in 2020
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Flag link:
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
AbbVie
Allergan
M&A
Sosei
Flag link:
The top medtech deals of 2020 (and one that got away)
The top medtech deals of 2020 (and one that got away)
Medtech Dive
devices
Medtech
M&A
Teladoc
Livongo Health
Stryker
Wright Medical
Medtronic
EXACT Sciences
Philips
BioTelemetry
Illumina
Grail
Siemens
Varian
Flag link:
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
Endpoints
Arvelle Therapeutics
Angelini Pharma
M&A
CNS
epilepsy
cenobamate
Axovant
Flag link:
Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree
Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree
Endpoints
Charles River Labs
CROs
M&A
Distribution Bio
Flag link:

Pages